IP Library › Granted Patent US 8,109,920

Granted Patent B2

US 8,109,920 · App. 12/001,983 · Granted Feb 7, 2012

Medical or veterinary digestive tract utilization systems and methods

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 8,109,920
App. No.: 12/001,983
Granted: Feb 7, 2012
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

Systems and methods are described for implementing or deploying medical or veterinary utility modules comprising a first module operable in a digestive or respiratory tract to engage a second module, optionally by a magnetic field. Alternatively or additionally, systems may be operable to remain in situ and also operable to permit a therapeutic material dispensation. In some contexts, for example, systems or methods may dispense a therapeutic material via a subject's throat or elsewhere in the digestive or respiratory tract.

Claims (59)

1. A medical or veterinary system comprising:

at least one module including at least one portion operable to contain at least one therapeutic material and at least one other portion operable to support the at least one portion in an oral cavity directly or indirectly for more than a day; and

one or more artificial conduits operable to guide the at least one therapeutic material and to extend from the at least one module to at least one digestive site or respiratory site other than the oral cavity.

2. The system of claim 1 , wherein the at least one module including at least one portion operable to contain at least one therapeutic material and at least one other portion operable to support the at least one portion in an oral cavity directly or indirectly for more than a day comprises:

at least one module including at least one portion operable to contain at least one therapeutic material and at least one other portion operable to releasably support the at least one portion in an oral cavity directly or indirectly for more than a day.

3. The system of claim 1 , wherein the at least one module including at least one portion operable to contain at least one therapeutic material and at least one other portion operable to support the at least one portion in an oral cavity directly or indirectly for more than a day comprises:

at least one module including at least one portion operable to contain at least one therapeutic material and at least one other portion operable to support the at least one portion in a mouth region directly or indirectly for more than a day.

4. The system of claim 1 , wherein the at least one module including at least one portion operable to contain at least one therapeutic material and at least one other portion operable to support the at least one portion in an oral cavity directly or indirectly for more than a day comprises:

5. The system of claim 1 , wherein the at least one module including at least one portion operable to contain at least one therapeutic material and at least one other portion operable to support the at least one portion in an oral cavity directly or indirectly for more than a day comprises:

6. The system of claim 1 , wherein the at least one module including at least one portion operable to contain at least one therapeutic material and at least one other portion operable to support the at least one portion in an oral cavity directly or indirectly for more than a day comprises:

7. The system of claim 1 , wherein the at least one module including at least one portion operable to contain at least one therapeutic material and at least one other portion operable to support the at least one portion in an oral cavity directly or indirectly for more than a day comprises:

at least one magnetically manipulable module including at least one portion operable to contain at least one therapeutic material and at least one other portion operable to support the at least one portion in an oral cavity directly or indirectly for more than a day.

8. The system of claim 1 , wherein the at least one module including at least one portion operable to contain at least one therapeutic material and at least one other portion operable to support the at least one portion in an oral cavity directly or indirectly for more than a day comprises:

at least one module associatable with at least one other module and including at least one portion operable to contain at least one therapeutic material and at least one other portion operable to support the at least one portion in an oral cavity directly or indirectly for more than a day.

9. The system of claim 1 , wherein the at least one module including at least one portion operable to contain at least one therapeutic material and at least one other portion operable to support the at least one portion in an oral cavity directly or indirectly for more than a day comprises:

at least one module configured to exit via the digestive tract per vias naturales including at least one portion operable to contain at least one therapeutic material and at least one other portion operable to support the at least one portion in an oral cavity directly or indirectly for more than a day.

10. The system of claim 1 , wherein the at least one module including at least one portion operable to contain at least one therapeutic material and at least one other portion operable to support the at least one portion in an oral cavity directly or indirectly for more than a day comprises:

at least one module including at least one portion operable to contain two or more therapeutic materials and at least one other portion operable to support the at least one portion in an oral cavity directly or indirectly for more than a day.

11. The system of claim 1 , wherein the at least one module including at least one portion operable to contain at least one therapeutic material and at least one other portion operable to support the at least one portion in an oral cavity directly or indirectly for more than a day comprises:

at least one module including at least one portion operable to contain more than one dosage of at least one therapeutic material and at least one other portion operable to support the at least one portion in an oral cavity directly or indirectly for more than a day.

12. The system of claim 1 , wherein the at least one module including at least one portion operable to contain at least one therapeutic material and at least one other portion operable to support the at least one portion in an oral cavity directly or indirectly for more than a day comprises:

at least one module including at least one pressurizable portion operable to contain at least one therapeutic material and at least one other portion operable to support the at least one pressurizable portion in an oral cavity directly or indirectly for more than a day.

13. The system of claim 1 , wherein the one or more artificial conduits operable to guide the at least one therapeutic material and to extend from the at least one module to at least one digestive site or respiratory site other than the oral cavity comprises:

one or more artificial conduits operable to guide the at least one therapeutic material and to extend from the at least one module to or through a throat.

14. The system of claim 1 , wherein the one or more artificial conduits operable to guide the at least one therapeutic material and to extend from the at least one module to at least one digestive site or respiratory site other than the oral cavity comprises:

one or more artificial conduits operable to guide the at least one therapeutic material and to extend from the at least one module to or through an esophagus.

15. The system of claim 1 , wherein the one or more artificial conduits operable to guide the at least one therapeutic material and to extend from the at least one module to at least one digestive site or respiratory site other than the oral cavity comprises:

one or more artificial conduits operable to guide the at least one therapeutic material and to extend from the at least one module to or through a gastric compartment.

16. The system of claim 1 , wherein the one or more artificial conduits operable to guide the at least one therapeutic material and to extend from the at least one module to at least one digestive site or respiratory site other than the oral cavity comprises:

one or more artificial conduits operable to guide the at least one therapeutic material and to extend from the at least one module to or through an intestine.

17. The system of claim 1 , wherein the one or more artificial conduits operable to guide the at least one therapeutic material and to extend from the at least one module to at least one digestive site or respiratory site other than the oral cavity comprises:

one or more artificial conduits operable to guide the at least one therapeutic material and to extend from the at least one module to at least one second module.

18. The system of claim 1 , wherein the one or more artificial conduits operable to guide the at least one therapeutic material and to extend from the at least one module to at least one digestive site or respiratory site other than the oral cavity comprises:

one or more artificial fixed length conduits operable to guide the at least one therapeutic material and to extend from the at least one module to at least one digestive site or respiratory site other than the oral cavity.

19. The system of claim 1 , further comprising:

one or more dispensers.

20. The system of claim 1 , further comprising:

one or more propellants.

21. The system of claim 1 , further comprising:

one or more transmitters.

22. The system of claim 1 , further comprising:

at least one receiver.

23. The system of claim 1 , further comprising:

one or more sensors.

24. The system of claim 1 , further comprising:

one or more control circuitries operable to control release of the at least one therapeutic material.

25. The system of claim 1 , further comprising:

one or more control circuitries operable to control release of the at least one therapeutic material in response to one or more parameter values determined using one or more sensors.

26. The system of claim 1 , further comprising:

one or more control circuitries operable to control release of the at least one therapeutic material in response to one or more program instructions.

27. The system of claim 1 , further comprising:

one or more control circuitries operable to control disengagement of the at least one module.

28. The system of claim 1 , further comprising:

at least one second module operable to associate with the at least one first module.

29. The system of claim 1 , further comprising:

at least one second module operable to associate with the one or more artificial conduits.

Assignments (3)

ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2016

From: THE INVENTION SCIENCE FUND I LLC

To: GEARBOX, LLC

Reel/Frame 037540/0134 →

ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2012

From: SEARETE LLC

To: THE INVENTION SCIENCE FUND I, LLC

Reel/Frame 028166/0097 →

ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2008

From: BOYDEN, EDWARD S.; HYDE, RODERICK A.; ISHIKAWA, MURIEL Y.; KARE, JORDIN T.; LANGER, ROBERT; LEUTHARDT, ERIC C.; RIVET, DENNIS J.; SMITH, MICHAEL A.; WHITMER, CHARLES; WOOD, JR., LOWELL L.; WOOD, VICTORIA Y.H.

To: SEARETE LLC

Reel/Frame 020786/0621 →